EUVIMEDEUVIMED entdecken
Querschnittstudie

Perspectives on Newer Antiobesity Drugs (Semaglutide and Tirzepatide) among Healthcare Professionals Treating Obesity in South Asia: A Cross-sectional Survey

Khushboo Agarwal iD, Lakshmi Nagendra iD, Saptarshi Bhattacharya iD, Sourabh Sharma iD, Abm Kamrul-Hasan iD, Nitin Kapoor iD, Dina Shreshtha, Sambit Das, Shehla Sheikh, Rucha Mehta, Aswin Pankaj, Musarrat Riaz und 1 weitere

Journal of The Association of Physicians of India · 2026

DOI: 10.59556/japi.74.1709 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of The Association of Physicians of India, 2026. Verfasst von Khushboo Agarwal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Ganesh Shankar Vidyarthi Memorial Medical College, Kanpur, Uttar Pradesh, India, *Corresponding Author. Hauptthemen laut MEDLINE: Tirzepatide, Anti-Obesity Agents, Obesity, Practice Patterns, Physicians'. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TirzepatideAnti-Obesity AgentsObesityPractice Patterns, Physicians'Attitude of Health PersonnelHealth PersonnelHumansSemaglutideCross-Sectional StudiesFemaleMaleAdultIndiaSurveys and QuestionnairesAsia, SouthernMiddle AgedSouth Asian PeopleHealth Knowledge, Attitudes, Practice

Stichwörter der Autor:innen

Antiobesity medicationsBiosimilarsHealthcare professionalsSouth Asia

Substanzen

TirzepatideSemaglutideAnti-Obesity Agents

Autor:innen und Institutionen

  • Department of Endocrinology, Ganesh Shankar Vidyarthi Memorial Medical College, Kanpur, Uttar Pradesh, India, *Corresponding Author.
  • Associate Professor, Department of Endocrinology, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, Karnataka, India.
  • Consultant, Department of Endocrinology, Max Super Specialty Hospital, Patparganj, Delhi, India.
  • Associate Professor, Department of Nephrology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, Delhi, India.
  • Department of Endocrinology, Mymensingh Medical College, Mymensingh, Mymensingh Division, Bangladesh.
  • Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, Tamil Nadu, India.

ORCID-Profile: Khushboo Agarwal, Lakshmi Nagendra, Saptarshi Bhattacharya, Sourabh Sharma, Abm Kamrul-Hasan, Nitin Kapoor, Sanjay Kalra

Zitieren

APA

Agarwal, K., Nagendra, L., Bhattacharya, S., Sharma, S., Kamrul-Hasan, A., Kapoor, N., Shreshtha, D., Das, S., Sheikh, S., Mehta, R., Pankaj, A., Riaz, M., & Kalra, S. (2026). Perspectives on Newer Antiobesity Drugs (Semaglutide and Tirzepatide) among Healthcare Professionals Treating Obesity in South Asia: A Cross-sectional Survey. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.74.1709

Vancouver

Agarwal K, Nagendra L, Bhattacharya S, Sharma S, Kamrul-Hasan A, Kapoor N, et al. Perspectives on Newer Antiobesity Drugs (Semaglutide and Tirzepatide) among Healthcare Professionals Treating Obesity in South Asia: A Cross-sectional Survey. Journal of The Association of Physicians of India. 2026. doi:10.59556/japi.74.1709

BibTeX
@article{Agarwal2026,
  author = {Agarwal, Khushboo and Nagendra, Lakshmi and Bhattacharya, Saptarshi and Sharma, Sourabh and Kamrul-Hasan, Abm and Kapoor, Nitin and Shreshtha, Dina and Das, Sambit and Sheikh, Shehla and Mehta, Rucha and Pankaj, Aswin and Riaz, Musarrat and Kalra, Sanjay},
  title = {Perspectives on Newer Antiobesity Drugs (Semaglutide and Tirzepatide) among Healthcare Professionals Treating Obesity in South Asia: A Cross-sectional Survey},
  journal = {Journal of The Association of Physicians of India},
  year = {2026},
  doi = {10.59556/japi.74.1709}
}
Kostenlos starten →